Evidence-Based Medicine Guidelines
Topical tacrolimus for atopic dermatitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Tacrolimus for Atopic Dermatitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458510/all/Topical_tacrolimus_for_atopic_dermatitis.
Topical tacrolimus for atopic dermatitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/all/Topical_tacrolimus_for_atopic_dermatitis. Accessed November 26, 2024.
Topical tacrolimus for atopic dermatitis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/all/Topical_tacrolimus_for_atopic_dermatitis
Topical Tacrolimus for Atopic Dermatitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/all/Topical_tacrolimus_for_atopic_dermatitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical tacrolimus for atopic dermatitis
ID - 458510
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458510/all/Topical_tacrolimus_for_atopic_dermatitis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
